TP53 and neoplasm: Based on our in vitro and in vivo (tumor sections) results, examining mitochondrial Phb1-p-p53(ser15) interaction following chemotherapy will enable one to predict the clinical outcome and chemoresponsiveness, and on decision on possible alternate treatment strategy.